Column

Clinical Pathways GPS

How the Proposed Elimination of Medicare Rebates Would Impact Clinical Pathways

11/18/2018

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

The Centers for Medicare & Medicaid Services (CMS) has published a range of new proposed and final rules regarding payment rates and policies affecting providers, payers, and patients. The Trump administration...

The...

11/18/2018

Journal of Clinical Pathways

Editorial

Charting a Path Forward for the Oncology Care Model

11/18/2018

Nicolas Ferreyros ;

The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...

The...

11/18/2018

Journal of Clinical Pathways

Editor's Page

Increasing Access to Innovative Therapies

10/15/2018

Winston Wong , PharmD;

Innovations in cancer therapy hold remarkable potential to transform treatment of the disease, but it is not enough to innovate new treatments if they are not easily accessible to patients. While the issue of access...

...

10/15/2018

Journal of Clinical Pathways

Editorial

Get to Know the Community Oncology Alliance

10/15/2018

Nicolas Ferreyros ;

The Community Oncology Alliance (COA) and Journal of Clinical Pathways (JCP) have joined in collaboration to keep JCP readers informed about news and research in the community oncology field, including available...

The...

10/15/2018

Journal of Clinical Pathways

Clinical Pathways GPS

Addressing High Drug Costs: Integrating Value Assessment Principles Into Clinical Pathways

10/15/2018

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, Matthew Pakizegee, PharmD, MS

The high cost of prescription medications is a common topic of debate in oncology care and in mainstream news. Many ideas on how to reduce drug prices have been proposed and debated, but stakeholders are not close to...

The...

10/15/2018

Journal of Clinical Pathways

PATIENT PERSPECTIVE

Talking About Costs of Care—Part Two: Integrating Discussions Into the Clinical Workflow

10/15/2018

Alan J. Balch , PhD, MSc;

In Part 1 of this 2-part column series on shared decision making, we discussed the need for health care teams to create a safe and inviting environment for patients to talk about financial concerns and questions...

In...

10/15/2018

Journal of Clinical Pathways

Clinical Pathways GPS

How Clinical Pathways Can Support Bundled Payment Models

09/13/2018

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

As the Blue Ribbon report of the Cancer Moonshot1 called for in 2016, we need to build the national cancer data ecosystem that is equal in dimension to the disease burden cancer imposes on society and the resources...

As the...

09/13/2018

Journal of Clinical Pathways

Editor's Page

Updating the Cancer Ecosystem: Access, Reimbursement, and Experience

09/13/2018

Winston Wong , PharmD;

The advancements made in health care, and oncology care specifically, have improved treatment and patient care tremendously, and have the potential to make an even greater impact as care delivery becomes more...

The...

09/13/2018

Journal of Clinical Pathways

Business of Pathways

Blockchain, Data Obstruction, and the Promise of Information Sharing for a Value-Based Health Care World

09/13/2018

Ira Klein , MD, MBA, FACP;

The current system of health care delivery and payment has tremendous inefficiencies that relate to an inability to share data among multiple parties, and from that sharing, glean useful and actionable information...

The...

09/13/2018

Journal of Clinical Pathways

Pharma Insights

Accreditation Explosion Among Top Specialty Pharmacy Trends

09/13/2018

Larry Blandford , PharmD;

Dominic Galante , MD, MS, PhD, CPCC;

As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...

As the...

09/13/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products